Drawing for Serial No. 76006304

USPTO serial 76006304

Serial No. 76006304

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RUPP, BRIAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 76006304?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark I. Peroff

MARK I PEROFF TRADEMARK & PATENT COUNSELORS ET AL915 BROADWAYNEW YORK, NY 10010-7108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical regents and catalysts for industrial and scientific purposes and laboratory research; diagnostic preparations for scientific purposes; chemical raw substances, catalysts and intermediary products, namely preservatives for pharmaceutical preparations and bases for use in the manufacture of pharmaceutical productsACTIVE—
003Body and beauty care products; face and skin care products, namely, astringents, beauty masks, cleansing milk for toilet purposes, cosmetic creams, lotions for cosmetic purposes, talcum powder for toilet use, dentifrices; essential oils for personal use and for use in the manufacture of pharmaceutical products; medicated soapsACTIVE—
005Pharmaceutical diagnostic, and veterinary preparations in galenic and oral administration forms, namely, alimentary and metabolic preparations, vitamins, hepatoprotectives, anti-emetics, anti-ulcer preparations, blood and clotting preparations, anti-anaemics, hypolipacemics, cardiovascular preparations, calcium ontagonists, anti-anginals; diuretics, anti-hypertensives, betablockers, peripheral and cerebral vasodilators; dermatologicals, genitourinary preparations, urinary anti-infectives, hormones, systemic and infectives, antibiotics, antibacterials, cytostatics, anti-rehumatics, anti-inflammatory agents, antigout preparations, neurological preparations, analgesics, antipyretics, antidepressants, anxiolytics, antiparasitics, antimalarials, respiratory preparations, antiasthmatics, expectorant and mucolytics, antitussives, cold preparations, ophthalmologicals, otologicals, antiallergics, immunostimulants and immunosuppressants; diagnostic reagents for medical purposes; X-ray contrast media for medical purposes; balsams for medical purposes; baby food; dietetic substances for medical purposes, namely, for the treatment of excess weight, medicinal tea and herb tea; dental restorative compounds for medical purposes; medical plasters; wound and surgical dressings; disinfectants for hygiene purposes; antiseptics; medicated hair shampoosACTIVE—
042Testing, analysis and evaluation of the goods and services of others in the field of medicine and pharmaceutics for the purpose of certification; providing quality assurance services in the field of chemical and pharmaceutical analyses; research and development for new pharmaceutical active ingredients, galenic formulations and administration forms of pharmaceutical products for others; patent agency and industrial property consultation in the areas of management, licensing and evaluation of industrial patent rights; development of computer software programs for data processing purposes for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 6, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 11, 2003EX1GSOU EXTENSION 1 GRANTED—
May 26, 2003EXT1SOU EXTENSION 1 FILED—
Nov 26, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 3, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2002NPUBNOTICE OF PUBLICATION—
Jun 7, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2002DOCKASSIGNED TO EXAMINER—
Apr 22, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2002MAILPAPER RECEIVED—
Oct 22, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance